- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | VENUS MEDTECH-B (02500): POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2025 ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): NOTICE OF 2025 ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): (1) 2025 ANNUAL REPORT (2) WORK REPORT OF THE BOARD FOR 2025 (3) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2025 (4) PROFIT ... | 3 | HKEx | ||
| 26.05. | Venus Medtech Hosts Inaugural Global Partner Summit in Paris | 420 | PR Newswire | Company highlights international growth strategy, expanding structural heart portfolio, and commercialization prioritiesPARIS, May 26, 2026 /PRNewswire/ -- Venus Medtech convened its inaugural... ► Artikel lesen | |
| 19.05. | VENUS MEDTECH-B (02500): EXCHANGE'S DISCIPLINARY ACTION AGAINST FORMER COMPANY SECRETARY OF VENUS MEDTECH (HANGZHOU) INC. (STOCK CODE: 2500) | 1 | HKEx | ||
| 15.05. | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 15.05. | VENUS MEDTECH-B (02500): RESIGNATION OF A DIRECTOR | - | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 06.05. | VENUS MEDTECH-B (02500): CHANGE OF COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVES | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2025 ANNUAL REPORT | 1 | HKEx | ||
| 31.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 | 1 | HKEx | ||
| 19.03. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | 3 | HKEx | ||
| 22.01. | VENUS MEDTECH-B (02500): FURTHER ANNOUNCEMENT IN RELATION TO THE PATENT INFRINGEMENT LAWSUIT | 1 | HKEx | ||
| 20.01. | VENUS MEDTECH-B (02500): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES | 1 | HKEx | ||
| 17.11.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion | 591 | PR Newswire | Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting.
LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech... ► Artikel lesen | |
| 25.10.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement | 743 | PR Newswire | The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch
HANGZHOU, China, Oct. 25, 2025 /PRNewswire/... ► Artikel lesen | |
| 05.08.25 | Venus Medtech (Hangzhou) Inc.: Court Sides with Cardiovalve in Edwards patent spat | 343 | PR Newswire | HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,440 | -1,67 % | FRESENIUS SE & CO KGAA: Stärke im Gleichgewicht | ||
| BRIGHTSPRING HEALTH SERVICES | 68,99 | +0,01 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,560 | -3,25 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,060 | -0,99 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| GERRESHEIMER | 27,500 | +4,09 % | Optimismus, verpufftes Goldman-Sachs-Signal und gebremste Erwartungen - Gerresheimer, Freenet, Volatus Aerospace | Eine erneute Eskalation zwischen USA und Iran mit Angriffen auf Ziele am Golf sowie Gegenschlägen wird die Risikoprämien am Montag an den Märkten erhöhen und stützt "sichere Häfen" wie Staatsanleihen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,270 | +0,34 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 25,350 | -4,09 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| BILLIONTOONE | 120,41 | +1,90 % | BillionToOne, Inc. - 8-K, Current Report | ||
| LIFESTANCE HEALTH GROUP | 10,335 | +0,54 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| HEARTFLOW | 34,860 | -2,22 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,600 | -5,00 % | DAX im Stress - Brenntag, Carl Zeiss Meditec, DWS, Infineon, RWE, Vonovia im Check | Der DAX steht zum Handelsstart unter Druck. Belastend wirken Gewinnmitnahmen in Asien und Schwäche in der Technologiebranche. Damit bleibt der Handel nahe der Rekordstände nervös, auch wenn von den... ► Artikel lesen | |
| PROGYNY | 28,860 | +1,23 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| GENEDX | 69,27 | -0,79 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| PROCEPT BIOROBOTICS | 22,590 | +0,13 % | Evercore ISI initiates Procept BioRobotics stock with outperform rating | ||
| RXSIGHT | 5,120 | -4,48 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
VENUS MEDTECH HANGZHOU INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.